HRW promotes Gillian Newbold to the board

pharmafile | April 7, 2011 | Appointment | Medical Communications |  apppointment, medical communications 

Healthcare research agency HRW has promoted Gillian Newbold to its board of directors.

Gillian joined the Oxfordshire, UK-based company in 2009 and is currently its research director (strategy).

She joins chairman Prof. David Thomson, managing director Caroline Jameson and deputy managing director Jeanette Kaye on the board, and HRW said Gillian’s passion for research and strategic thinking have made a significant contribution to its continued growth and success.

Advertisement

Related Content

Rare diseases – spinal muscular atrophy

Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

Men’s health – a new report from the Department of Health and Social Care

The UK Department of Health and Social Care has published a new report entitled Men’s …

The Gateway to Local Adoption Series

Latest content